Literature DB >> 15504944

Association of chronic kidney disease and anemia with physical capacity: the heart and soul study.

Michelle C Odden1, Mary A Whooley, Michael G Shlipak.   

Abstract

Chronic kidney disease (CKD) and anemia are common conditions in the outpatient setting, but their independent and additive effects on physical capacity have not been well characterized. The association of CKD and anemia with self-reported physical function was evaluated and exercise capacity was measured in patients with coronary disease. A cross-sectional study of 954 outpatients enrolled in the Heart and Soul study was performed. CKD was defined as a measured creatinine clearance <60 ml/min, and anemia was defined as a hemoglobin level of <12g/dl. Physical function was self-assessed using the physical limitation subscale of the Seattle Angina Questionnaire (0 to 100), and exercise capacity was defined as metabolic equivalent tasks achieved at peak exercise. In unadjusted analyses, CKD was associated with lower self-reported physical function (67.6 versus 74.9; P < 0.001) and lower exercise capacity (5.5 versus 7.9; P < 0.001). Similarly, anemia was associated with lower self-reported physical function (62.6 versus 74.3; P < 0.001) and exercise capacity (5.7 versus 7.5; P < 0.001). After multivariate adjustment, CKD (69.4 versus 74.2; P = 0.003) and anemia (67.5 versus 73.6; P = 0.009) each remained associated with lower mean self-reported physical function. In addition, patients with CKD (6.3 versus 7.7; P < 0.001) or anemia (6.5 versus 7.4; P = 0.004) had lower adjusted mean exercise capacities. Participants with both CKD and anemia had lower self-reported physical function and exercise capacity than those with either alone. CKD and anemia are independently associated with physical limitation and reduced exercise capacity in outpatients with coronary disease, and these effects are additive. The broad impact of these disease conditions merits further study.

Entities:  

Mesh:

Year:  2004        PMID: 15504944      PMCID: PMC2776664          DOI: 10.1097/01.ASN.0000143743.78092.E3

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  29 in total

1.  IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000.

Authors: 
Journal:  Am J Kidney Dis       Date:  2001-01       Impact factor: 8.860

2.  Twelve weeks of exercise training increases muscle function and walking capacity in elderly predialysis patients and healthy subjects.

Authors:  S Heiwe; A Tollbäck; N Clyne
Journal:  Nephron       Date:  2001-05       Impact factor: 2.847

3.  Physical performance and associated electrolyte changes after haemoglobin normalization: a comparative study in haemodialysis patients.

Authors:  L P McMahon; M J McKenna; T Sangkabutra; K Mason; S Sostaric; S L Skinner; C Burge; B Murphy; D Crankshaw
Journal:  Nephrol Dial Transplant       Date:  1999-05       Impact factor: 5.992

4.  Validation of questionnaires to estimate physical activity and functioning in end-stage renal disease.

Authors:  K L Johansen; P Painter; J A Kent-Braun; A V Ng; S Carey; M Da Silva; G M Chertow
Journal:  Kidney Int       Date:  2001-03       Impact factor: 10.612

5.  Increasing the hematocrit has a beneficial effect on quality of life and is safe in selected hemodialysis patients. Spanish Cooperative Renal Patients Quality of Life Study Group of the Spanish Society of Nephrology.

Authors:  Fuensanta Moreno; Dámaso Sanz-Guajardo; Juan Manuel López-Gómez; Rosa Jofre; Fernando Valderrábano
Journal:  J Am Soc Nephrol       Date:  2000-02       Impact factor: 10.121

6.  Physical activity levels in patients on hemodialysis and healthy sedentary controls.

Authors:  K L Johansen; G M Chertow; A V Ng; K Mulligan; S Carey; P Y Schoenfeld; J A Kent-Braun
Journal:  Kidney Int       Date:  2000-06       Impact factor: 10.612

7.  Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients.

Authors:  D A Revicki; R E Brown; D H Feeny; D Henry; B P Teehan; M R Rudnick; R L Benz
Journal:  Am J Kidney Dis       Date:  1995-04       Impact factor: 8.860

8.  Improvement in exercise capacity after correction of anemia in patients with end-stage renal failure.

Authors:  M Metra; G Cannella; G La Canna; T Guaini; M Sandrini; M Gaggiotti; E Movilli; L Dei Cas
Journal:  Am J Cardiol       Date:  1991-10-15       Impact factor: 2.778

9.  Progressive decline in renal function induces a gradual decrease in total hemoglobin and exercise capacity.

Authors:  N Clyne; T Jogestrand; L E Lins; S K Pehrsson
Journal:  Nephron       Date:  1994       Impact factor: 2.847

10.  Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease.

Authors:  J A Spertus; J A Winder; T A Dewhurst; R A Deyo; J Prodzinski; M McDonell; S D Fihn
Journal:  J Am Coll Cardiol       Date:  1995-02       Impact factor: 24.094

View more
  38 in total

1.  Optimizing anemia management through medication reconciliation: applying the 2010 joint commission patient safety goal requirements.

Authors:  Shilpa Amara; Indu Lew; Robert T Adamson
Journal:  P T       Date:  2010-03

2.  Anemia treatment with Q2W darbepoetin alfa in patients with chronic kidney disease naïve to erythropoiesis-stimulating agents.

Authors:  M R Silver; R Geronemus; M Krause; C Y Chen; R Kewalramani; C Stehman-Breen
Journal:  Curr Med Res Opin       Date:  2009-01       Impact factor: 2.580

Review 3.  Aging and chronic kidney disease: the impact on physical function and cognition.

Authors:  Shuchi Anand; Kirsten L Johansen; Manjula Kurella Tamura
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-08-02       Impact factor: 6.053

4.  Timing of erythropoiesis-stimulating agent initiation and adverse outcomes in nondialysis CKD: a propensity-matched observational study.

Authors:  Stephen Seliger; Kathleen M Fox; Shravanthi R Gandra; Brian Bradbury; Van Doren Hsu; Loreen Walker; Chiun-Fang Chiou; Jeffrey C Fink
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-18       Impact factor: 8.237

5.  Depression, stress, and quality of life in persons with chronic kidney disease: the Heart and Soul Study.

Authors:  Michelle C Odden; Mary A Whooley; Michael G Shlipak
Journal:  Nephron Clin Pract       Date:  2005-12-07

Review 6.  Physical inactivity: a risk factor and target for intervention in renal care.

Authors:  Dorien M Zelle; Gerald Klaassen; Edwin van Adrichem; Stephan J L Bakker; Eva Corpeleijn; Gerjan Navis
Journal:  Nat Rev Nephrol       Date:  2017-01-31       Impact factor: 28.314

7.  A pilot study to relationship between urinary protein excretion and muscle strengthening in patients with acute onset renal disease.

Authors:  Kohji Iwai; Yasuhiko Hatanaka
Journal:  Phys Ther Res       Date:  2018-07-15

8.  Exercise as an Adjunct Therapy In Chronic Kidney Disease.

Authors:  Danielle L Kirkman; David G Edwards; Shannon Lennon-Edwards
Journal:  Renal Nutr Forum       Date:  2014

9.  Impact of chronic kidney disease and anemia on physical function in patients with chronic heart failure.

Authors:  Masakazu Saitoh; Haruki Itoh; Nobuo Morotomi; Tetsuya Ozawa; Noriko Ishii; Reina Uewaki; Kentaro Hori; Yohei Shiotani; Miki Ando; Shogo Nakashima; Kana Kawai; Azusa Ohno; Masatoshi Nagayama
Journal:  Cardiorenal Med       Date:  2014-04-17       Impact factor: 2.041

10.  Serum creatinine and functional limitation in elderly persons.

Authors:  Michelle C Odden; Michael G Shlipak; Ira B Tager
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-01-30       Impact factor: 6.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.